S'abonner

Characterizing respiratory syncytial virus (RSV) infections before and during the COVID-19 pandemic - 12/12/24

Doi : 10.1016/j.ajem.2024.11.002 
Saamia I. Masoom, MD a, , Gina Aloisio, MD PhD a , Elizabeth A. Camp, PhD a , James J. Dunn, PhD b , Sarah D. Meskill, MD MS a
a Division of Pediatric Emergency Medicine, Department of Pediatrics, Baylor College of Medicine, 6621 Fannin St., Suite A210, Houston, TX 77030, United States of America 
b Department of Pathology & Immunology, Baylor College of Medicine, One Baylor Plaza, BCM 315, Houston, TX 77030, United States of America 

Corresponding author.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

Following the onset of the COVID-19 pandemic, RSV infections deviated from a previously reliable epidemiologic pattern of presentation. To investigate whether this change in RSV seasonality resulted in a change in frequency and severity of RSV infections, this single center retrospective study compares demographic and hospital factors during RSV seasons before and after the onset of the COVID-19 pandemic.

Methods

Included were patients under age 5 years who tested positive for RSV only by RT-PCR in our pediatric emergency departments during the last three RSV seasons before the onset of the COVID-19 pandemic in spring 2020, as compared to the first three seasons after the pandemic started. RSV seasonality was defined as periods in which greater than 10 % of all RSV RT-PCR tests sent resulted positive. Patients with tracheostomies were excluded, as were duplicate tests performed in the same patient within 1 day. Demographic data obtained included patient age, sex, and weight. Hospital factors obtained were inpatient admission and length of stay (LOS), intensive care unit (ICU) admission and LOS, respiratory support during the encounter, and mortality. A planned subgroup analysis isolating the first RSV season after the pandemic's onset was performed. Mann-Whitney and Pearson Chi-Square testing were used for comparison of continuous and categorical variables, respectively. Significance was set at p < 0.05.

Results

RSV seasons were identified with 7592 cases meeting study criteria (2770 cases before the pandemic's onset and 4822 cases after). While there were more RSV cases identified per season after the onset of COVID-19, testing also increased in this period. RSV positive patients in seasons after the onset of COVID-19 were significantly older than those in seasons before (0.83 years vs. 0.56 years, p < 0.001). They were admitted to the hospital significantly less (46.8 % vs. 54.9 %, p < 0.001), though ICU admission rates did not change significantly (32.9 % vs. 31.1 %, p = 0.25). Both inpatient LOS (64 h vs. 60 h, p = 0.01) and ICU LOS (68 h vs. 88.5 h, p < 0.001) decreased significantly. RSV positive inpatients in seasons after the onset of COVID-19 were significantly more likely to require respiratory support (89.0 % vs. 86.5 %, p = 0.02), with more requiring BIPAP (11.3 % vs. 8.1 %, p = 0.003) and fewer requiring intubation (9.6 % vs. 13.8 %, p < 0.001).

Conclusions

During the first three RSV seasons after the onset of the COVID-19 pandemic, our pediatric emergency departments saw more RSV positive patients than in the last three seasons beforehand. These patients were significantly older and less likely to be admitted, which may be partly due to increased respiratory viral testing during the pandemic. However, shorter LOS and decreased intubations despite increased respiratory support among admitted patients may indicate a paradigm shift in emergency department and inpatient management of severe RSV infections, perhaps encouraged by practice changes and resource limitations due to COVID-19. This information may better guide institutions in predicting resource needs after large-scale infectious disease outbreaks in the future.

Le texte complet de cet article est disponible en PDF.

Highlights

The COVID-19 pandemic elicited changes to the presentation of RSV in the ED.
RSV patients were older, admitted less, had shorter LOS, and used more BIPAP.
Increased age supports the theory of an ‘immunity gap’ following pandemics.
Admission and respiratory data suggest a paradigm shift in RSV management.
This data may help institutions plan for resources needed after future pandemics.

Le texte complet de cet article est disponible en PDF.

Keywords : Respiratory syncytial virus, COVID-19, Epidemiology, Pandemic, Pediatrics, Hospitalization


Plan


© 2024  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 87

P. 108-112 - janvier 2025 Retour au numéro
Article précédent Article précédent
  • Signs of life as a favorable predictor for non-shockable cardiac arrest undergoing extracorporeal cardiopulmonary resuscitation post non-shockable cardiac arrest
  • Naofumi Bunya, Hirofumi Ohnishi, Takehiko Kasai, Ryo Nishikawa, Keigo Sawamoto, Shuji Uemura, Narimatsu Eichi
| Article suivant Article suivant
  • Prognostic value of gray–white matter ratio measured by brain MRI-based CT structures in comatose patients after cardiac arrest
  • Sung Jin Bae, Yoon Hee Choi, Seok Jin Ryu, Dong Hun Lee, Yunhyung Choi, Minsoo Chun, Youngwoo Kim, Dong Hoon Lee

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.